Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066439
Filing Date
2025-05-08
Accepted
2025-05-08 08:35:12
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sln-20250331.htm   iXBRL 10-Q 1561656
2 EX-31.1 sln-ex31_1.htm EX-31.1 15668
3 EX-31.2 sln-ex31_2.htm EX-31.2 15532
4 EX-32.1 sln-ex32_1.htm EX-32.1 10070
  Complete submission text file 0000950170-25-066439.txt   6916738

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sln-20250331.xsd EX-101.SCH 1158939
70 EXTRACTED XBRL INSTANCE DOCUMENT sln-20250331_htm.xml XML 1065826
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 10-Q | Act: 34 | File No.: 001-39487 | Film No.: 25924069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)